We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

127 hedge funds and large institutions have $783M invested in Arcturus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

64% more call options, than puts

Call options by funds: $27M | Put options by funds: $16.5M

29% more capital invested

Capital invested by funds: $606M → $783M (+$177M)

11.48% more ownership

Funds ownership: 63.2% → 74.68% (+11%)

11% more funds holding

Funds holding: 114 → 127 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
127
Holders Change
+13
Holders Change %
+11.4%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
33
Increased
54
Reduced
28
Closed
20
Calls
$27M
Puts
$16.5M
Net Calls
+$10.6M
Net Calls Change
+$14.5M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$74.5M
2
State Street
State Street
Massachusetts
+$64.6M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$37.8M
4
AIM
ARK Investment Management
Florida
+$28.6M
5
O
OrbiMed
New York
+$18.8M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$25.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$19.3M
3
Invesco
Invesco
Georgia
-$10.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.4M
5
CH
CVI Holdings
Delaware
-$9.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Sumitomo Mitsui Trust Group
26
Sumitomo Mitsui Trust Group
Japan
$5.63M -$754K -15,182 -10%
NAMA
27
Nikko Asset Management Americas
New York
$5.63M -$611K -12,317 -9%
Charles Schwab
28
Charles Schwab
California
$5.02M +$4.14M +83,449 +248%
CIA
29
Capital Impact Advisors
Massachusetts
$4.72M +$5.46M +110,000 New
GPCM
30
Granite Point Capital Management
Massachusetts
$4.29M +$2.48M +50,000 +100%
RA
31
Royce & Associates
New York
$3.42M – – –
CS
32
Candriam SCA
Luxembourg
$3.42M – – –
Wells Fargo
33
Wells Fargo
California
$3.26M +$544K +10,953 +17%
CS
34
Credit Suisse
Switzerland
$3.24M +$2.95M +59,346 +366%
KCM
35
Kennedy Capital Management
Missouri
$3.21M +$3.71M +74,807 New
N
36
Nuveen
North Carolina
$3.1M +$484K +9,745 +16%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.69M +$491K +9,897 +19%
Schroder Investment Management Group
38
Schroder Investment Management Group
United Kingdom
$2.59M +$3M +60,428 New
Ameriprise
39
Ameriprise
Minnesota
$2.42M -$694K -13,978 -20%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$2.21M +$2.55M +51,404 New
CCPM
41
Cooper Creek Partners Management
New York
$2.17M – – –
Creative Planning
42
Creative Planning
Kansas
$1.9M +$97.7K +1,968 +5%
JP Morgan Chase
43
JP Morgan Chase
New York
$1.86M +$463K +9,320 +27%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.86M +$496K +10,000 +30%
WP
45
Woodline Partners
California
$1.67M -$5.41M -109,067 -74%
ECM
46
ExodusPoint Capital Management
New York
$1.59M +$1.84M +37,055 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.57M +$358K +7,216 +25%
ECM
48
Endurant Capital Management
California
$1.48M +$1.71M +34,485 New
Morgan Stanley
49
Morgan Stanley
New York
$1.43M -$5.9M -118,906 -78%
AA
50
ALPS Advisors
Colorado
$1.33M +$156K +3,148 +11%
1
2
3 4 5

ARCT Hedge Fund Activity: Q3 2020 in Review

127 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2020, worth a combined $783M — up 29% from $606M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARCT positions and 20 closed out — a net gain of 13 holders — while 54 added to existing stakes and 28 trimmed.

The largest buyer was HealthCor Management, adding an estimated $74.5M. The largest seller was Deutsche Bank, cutting an estimated $25.4M.

  • 127 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2020, up from 114 in Q2 2020.
  • Funds reported $783M of Arcturus Therapeutics stock for Q3 2020, up 29% quarter-over-quarter.
  • 33 funds opened new Arcturus Therapeutics positions in Q3 2020 and 20 closed out, a net change of +13 holders.
  • The largest Arcturus Therapeutics buyer in Q3 2020 was HealthCor Management, an estimated $74.5M added.
  • The largest Arcturus Therapeutics seller in Q3 2020 was Deutsche Bank, an estimated $25.4M sold.

Based on aggregated 13F filings for Q3 2020.